Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒)

Zhang  Ying; Chang Jing; Chi Huan-hai; Mao Bing; Tang Wen-fu; Wang Lei; Huang Su-zhen; Li Ting-qian; Zhang Rui-ming

doi:10.1007/s11655-007-0027-7

Your Location：

Home >

Browse articles >

Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒)

Updated：2021-08-27

- Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒)
- Chinese Journal of Integrative Medicine Vol. 13, Issue 1, Pages: 27-32(2007)
- Affiliations：
  
  Department of Integrative Chinese and Western Medicine, Huaxi Hospital of Sichuan University,Chengdu,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-007-0027-7
  CLC：
- Published：2007，
Scan for full text
Zhang, Y., Chang, J., Chi, Hh. et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒)., Chin. J Integ. Med. 13, 27–32 (2007). https://doi.org/10.1007/s11655-007-0027-7

Zhang Ying, Chang Jing, Chi Huan-hai, et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒). [J]. Chinese Journal of Integrative Medicine 13(1):27-32(2007)
Zhang, Y., Chang, J., Chi, Hh. et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒)., Chin. J Integ. Med. 13, 27–32 (2007). https://doi.org/10.1007/s11655-007-0027-7 DOI：

Zhang Ying, Chang Jing, Chi Huan-hai, et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒). [J]. Chinese Journal of Integrative Medicine 13(1):27-32(2007) DOI： 10.1007/s11655-007-0027-7.

摘要

To evaluate the effect and safety of Pingchuan Yiqi Granule (平喘益气颗粒

PYG) in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC). With the randomized

positive agent parallel controlled design adopted

the 80 subjects enrolled were assigned in the ratio of 3:1 to two groups

the 60 patients in the trial group were treated with PYG and the 20 in the control group treated with Ruyi Dingchuan Pill (如意定喘丸

RDP)

with the therapeutic course consisting of 7 days for both groups. The clinical effects

effects on TCM syndrome and the changes of lung function after treatment were observed. The effect of the treatment on asthma in the trial group: clinically controlled rate was 6.67%

markedly effective rate 51.67%

improved rate 33.33% and ineffective rate 8.33%; and the corresponding rates in the control group were 5.00%

50.00%

30.00%

and 15.00% respectively. Comparison between the two groups showed insignificant difference (P>0.05). The effect on TCM syndrome in the treated group: clinically controlled rate was 11.67%

markedly effective rate 58.33%

effective rate 21.67% and ineffective rate 8.33%; and those in the control group were 10.00%

50.00%

30.00% and 10.00% respectively

also showing insignificant difference between the two groups (P>0.05). Lung function test showed that the change on forced expiratory volume in 1 second (FEV1) after treatment in the trial group was of statistical significance (P<0.05)

but no significant difference was shown in the change of peak expiratory flow (PEF

P>0.05); while the changes in the control group were just the opposite

showing insignificance in FEV1 (P>0.05) but significance in PEF (P<0.05). Comparison of the therapeutic effect on lung function between the two groups showed no significant difference (P>0.05). No adverse reaction was found in either group in the course of treatment. PYG used to treat BS-QDC is effective and safe

it’s effect is similar to that of RDP.

Abstract

To evaluate the effect and safety of Pingchuan Yiqi Granule (平喘益气颗粒

PYG) in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC). With the randomized

positive agent parallel controlled design adopted

the 80 subjects enrolled were assigned in the ratio of 3:1 to two groups

the 60 patients in the trial group were treated with PYG and the 20 in the control group treated with Ruyi Dingchuan Pill (如意定喘丸

RDP)

with the therapeutic course consisting of 7 days for both groups. The clinical effects

effects on TCM syndrome and the changes of lung function after treatment were observed. The effect of the treatment on asthma in the trial group: clinically controlled rate was 6.67%

markedly effective rate 51.67%

improved rate 33.33% and ineffective rate 8.33%; and the corresponding rates in the control group were 5.00%

50.00%

30.00%

and 15.00% respectively. Comparison between the two groups showed insignificant difference (P>0.05). The effect on TCM syndrome in the treated group: clinically controlled rate was 11.67%

markedly effective rate 58.33%

effective rate 21.67% and ineffective rate 8.33%; and those in the control group were 10.00%

50.00%

30.00% and 10.00% respectively

but no significant difference was shown in the change of peak expiratory flow (PEF

P>0.05); while the changes in the control group were just the opposite

it’s effect is similar to that of RDP.

关键词

Pingchuan Yiqi Granulerandomized controlled trialbronchial asthmaqi-deficiency cold syndrome type

Keywords

Pingchuan Yiqi Granulerandomized controlled trialbronchial asthmaqi-deficiency cold syndrome type

references

Ministry of Health, P.R.C. Principle of guidance on clinical study of TCM new drugs. Vol. 1. 1993: 6–10.

Branch of Respiratory Diseases of the Chinese Association of Medicine. Directory of bronchial asthma prevention and treatment. Chin J Tuberc Respir Dis 1997; 20(5): 261–267.

State Supervisory Administration of Foods and Drugs. Technologic requirement for researches of TCM new drugs. 1999: 34–37.

Ya Ka zu Doumei. Explanation on the recipes used in clinic. Beijing: People’s Medical Publishing House, 1983: 221.

Li BG. Treatment of children asthma with Shenmi Decoction. J Pract Tradit Chin Med 2000;14(1): 45.

Fang D, Kou TQ. Twenty-nine patients of chronic asthmatic bronchitis in acute stage treated mainly with Shenmi Decoction. J Pract Tradit Chin Med 1998;14(3): 11.

Zand LJ. Treatment of chronic cough and asthma with Kampo medicine. Foreign Med Sci (Tradit Chin Med) 2005;27(5): 290–293.

FULL TEXT LINK

More>

Views

332

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”

A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

Efficacy of Gastrosis No.1 compound on functional dyspepsia of spleen and stomach deficiency-cold syndrome: A multi-center, double-blind, placebo-controlled clinical trial

Syndrome pattern and its application in parallel randomized controlled trials

Related Author

No data

Related Institution

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine

First Hospital Affiliated to Tianjin University of Traditional Chinese Medicine

Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine

Department of Epidemiology and Biostatistics, School of Public Health, Peking University

Fujian Provincial Cardiovascular Disease Institute, Provincial Clinical College of Fujian Medical University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰